Patient Population Studies

Patient Population Studies

PHASE III CLINICAL TRIALS EXPERTISE

Actimus Bio specialises in the planning, management, execution, and analysis of your Phase 3 clinical trials, with functional and therapeutic expertise, which includes cardio-metabolic, Dermatology, Gastroenterology/Hepatology, Oncology/Hematology, infectious diseases, neurology/psychiatry, rare disease and more. We help you find the most appropriate locations, most qualified investigators and best patient enrolment populations.
 
Comprehensive and Secure CTMS

We provide you with one the comprehensive and secure CTMS which enables tracking and reporting of all study activities through a secure, fully configurable, trial-specific application from study planning through close-out and Regulatory submission. Our CTMS supports every study aspect, including design, procedures, protocol, study arms, visits, forms, and treatments.
With our cloud based CTMS is cloud-based, you can view and manage near real-time operational performance of clinical trial activities at any time. It improves efficiencies in both data flow and workflow, yielding cost-savings in time and labour.

With our customized CTMS You can:

  • Access current information on site status, activation, enrolment, and monitoring visit schedule
  • Connect, export, and collaborate securely
  • Observe recruitment status and trial enrolment
  • Intervene early in potential enrolment delays
  • Manage planning and execution of monitoring visits, including visit windows
  • Generate custom and ad-hoc reports, including Monitor Visit Report
  • Securely access real-time data.
  • Track adverse events, action items, protocol deviations for sites and subjects
  •  Ensure study close-out is compliant with your SOP and with federal or international regulations.

Actimus Biosciences as a knowledge based CRO, was established in the year 2005.

Andhra Pradesh, India.
(Mon - Sat)
info@actimusbio.com
X